Filing Details

Accession Number:
0001140361-11-012029
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-24 18:58:28
Reporting Period:
2011-02-23
Filing Date:
2011-02-24
Accepted Time:
2011-02-24 18:58:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1114913 Pierre Lapalme C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-23 100 $8.47 18,850 No 4 M Direct
Common Stock Disposition 2011-02-23 100 $26.00 18,750 No 4 S Direct
Common Stock Acquisiton 2011-02-24 15,000 $5.92 33,750 No 4 M Direct
Common Stock Disposition 2011-02-24 15,000 $24.94 18,750 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2011-02-23 100 $0.00 100 $8.47
Common Stock Stock Option (right to buy) Disposition 2011-02-24 15,000 $0.00 15,000 $5.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
142,400 2004-04-27 2014-01-26 No 4 M Direct
127,400 2005-04-27 2015-01-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,500 Indirect Shares held by spouse
Footnotes
  1. The price in Column 4 is a weighted average price. The prices actually received range from $24.91 to $25.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  2. Original option grant vested 1/4 each on April 27, 2004, July 27, 2004, October 27, 2004, and January 27, 2005.
  3. Original option grant vested 1/4 each on April 27, 2005, July 27, 2005, October 27, 2005, and January 27, 2006.